Journal article : Comment
Nasally delivered SARS-CoV-2 vaccines: future promise and challenges
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 56.7KB, Terms of use)
-
- Publisher copy:
- 10.1016/s2213-2600(23)00383-1
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet Respiratory Medicine More from this journal
- Volume:
- 11
- Issue:
- 12
- Pages:
- 1038-1039
- Place of publication:
- England
- Publication date:
- 2023-11-15
- Acceptance date:
- 2023-10-13
- DOI:
- EISSN:
-
2213-2619
- ISSN:
-
2213-2600
- Pmid:
-
37979589
- Language:
-
English
- Subtype:
-
Comment
- Pubs id:
-
1574883
- Local pid:
-
pubs:1574883
- Source identifiers:
-
W4388713861
- Deposit date:
-
2026-07-06
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2023
- Rights statement:
- © 2023 Elsevier Ltd. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at https://dx.doi.org/10.1016/s2213-2600(23)00383-1
If you are the owner of this record, you can report an update to it here: Report update to this record